Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer (Q42723815)
Jump to navigation
Jump to search
scientific article published on 16 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer |
scientific article published on 16 November 2011 |
Statements
1 reference
Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer (English)
1 reference
Keith T Flaherty
1 reference
Keith D Wilner
1 reference
Patricia M Lorusso
1 reference
Angela Demichele
1 reference
Vandana G Abramson
1 reference
Rachel Courtney
1 reference
Sophia S Randolph
1 reference
M Naveed Shaik
1 reference
Peter J O'Dwyer
1 reference
Gary K Schwartz
1 reference
16 November 2011
1 reference
1 reference
Identifiers
1 reference